+38 063 723 45 66 Monday-Friday 10:00-17:00
Item added
Cart
  • Your shopping cart is empty
Total 0₴

MODACARE – potency product | Buy in Ukraine with delivery

Sort By:
MODACARE 200
MODACARE 200
Modafinil 200 mg
Number of tablets
300
MODACARE 300
MODACARE 300
Modafinil 300 mg
Number of tablets
380
MODACARE 400
MODACARE 400
Modafinil 400 mg
Number of tablets
450
MODACARE ELITE 200+50
MODACARE ELITE 200+50
Modafinil 200 mg + Armodafinil 50 mg
Number of tablets
450
MODACARE MD 200
MODACARE MD 200
Modafinil 200 mg
Number of tablets
380

What is MODACARE?

MODACARE is a medicinal product belonging to the pharmacological group of psychostimulants and nootropic agents with a pronounced effect on the central nervous system. The main purpose of the drug is the correction of conditions associated with increased daytime sleepiness, reduced concentration, and chronic fatigue that cannot be managed by non-pharmacological methods. The dosage form of MODACARE is oral tablets, which ensures convenient dosing and stable bioavailability of the active component. The drug is available in blisters that reliably protect the tablets from moisture and light, which is especially important for maintaining pharmacological activity. The manufacturer of MODACARE is a pharmaceutical company specializing in the development and production of drugs for neurological and psychiatric practice in compliance with international quality standards.

MODACARE is used as a means to improve mental performance and restore cognitive functions in patients suffering from sleep disorders or working shift schedules. The drug is not a classic amphetamine-type stimulant; therefore, the risk of developing euphoria and dependence is significantly lower compared to traditional psychostimulants. The mechanism of action of MODACARE is based on a selective effect on certain brain areas responsible for the sleep-wake cycle, which allows achieving a therapeutic effect without pronounced excitation of the peripheral nervous system. This makes the drug an attractive choice for patients requiring long-term support of attention and activity without significant strain on the cardiovascular system. It is important to understand that MODACARE is a prescription drug, and its administration should be carried out only by a doctor after a thorough examination.

In clinical practice, MODACARE has proven to be an effective agent for the treatment of narcolepsy, obstructive sleep apnea, and shift work sleep disorder. The drug helps patients maintain mental clarity and high energy levels throughout the day without causing a feeling of artificial agitation or anxiety. Due to the characteristics of pharmacokinetics, the active substance of MODACARE reaches peak plasma concentration two to three hours after ingestion, providing a predictable and controlled therapeutic effect. The elimination half-life is about twelve to fifteen hours, so the drug is usually taken once a day in the morning. This dosage regimen minimizes the risk of disrupting night sleep and provides a stable level of activity throughout the day.

What is MODACARE prescribed for?

The main indications for the use of MODACARE are conditions accompanied by pathological daytime sleepiness and a decline in cognitive performance. Most often, the drug is prescribed to patients diagnosed with narcolepsy — a chronic neurological disorder in which a person experiences uncontrollable sleep attacks during the day, regardless of the quality of nighttime rest. MODACARE helps stabilize the sleep-wake cycle, reducing the frequency of sudden sleep episodes and improving the patient's overall quality of life. The drug is also effective in obstructive sleep apnea syndrome, when nocturnal breathing cessations lead to sleep fragmentation and severe daytime fatigue. In such cases, MODACARE is used as an adjunct to the primary therapy aimed at eliminating the cause of apnea.

Another important indication for prescribing MODACARE is shift work sleep disorder, which occurs in people working night shifts or rotating schedules. Disruption of natural circadian rhythms leads to chronic sleep deprivation, reduced concentration, and an increased risk of errors in the workplace. MODACARE helps the body adapt to an unconventional routine, maintaining the necessary level of alertness during periods when a person must be active. The drug may also be prescribed for idiopathic hypersomnia — a condition in which a person sleeps a sufficient number of hours but still experiences constant sleepiness and exhaustion. In such cases, MODACARE allows restoring a normal level of daytime activity without the need to increase sleep duration.

In certain clinical situations, MODACARE is used to correct cognitive impairments associated with depressive states, chronic fatigue syndrome, or the consequences of traumatic brain injuries. The drug improves the ability to concentrate, increases the speed of information processing, and contributes to the restoration of mental capacity. However, it should be emphasized that MODACARE is not an antidepressant and does not replace specific therapy for psychiatric disorders. Its use in such cases is possible only as an auxiliary component of comprehensive treatment under medical supervision. Self-medication with MODACARE is unacceptable, as the drug has a serious impact on the central nervous system and requires individual dose adjustment.

Composition and active components of MODACARE

The active pharmaceutical ingredient of MODACARE is modafinil, a synthetic compound belonging to the class of benzhydrylsulfinylacetamides. Modafinil acts as a selective dopamine reuptake inhibitor, increasing the concentration of this neurotransmitter in the synaptic cleft, which enhances wakefulness signals in the brain. Unlike traditional psychostimulants, modafinil does not cause significant dopamine release in the nucleus accumbens, explaining its lower abuse potential and less pronounced euphoric effects. The drug also affects hypothalamic orexin neurons, which play a key role in regulating the sleep-wake cycle. This dual mechanism of action provides a sustained therapeutic effect without sharp fluctuations in mood or activity.

Excipients of MODACARE include lactose monohydrate, which acts as a filler and provides the necessary tablet mass, microcrystalline cellulose as a binding agent that imparts mechanical strength to the tablet, and sodium starch glycolate, which promotes rapid tablet disintegration in the gastrointestinal tract. The composition also includes magnesium stearate as a lubricant that prevents powder from adhering to compression equipment, and povidone, which improves the solubility of the active component. All excipients are of pharmacopoeial quality and have no independent pharmacological action, yet they ensure the stability of the drug throughout its shelf life. Patients with lactose intolerance should take its presence in MODACARE into account and inform their physician.

The mechanism of action of modafinil at the cellular level is associated with the modulation of the activity of the GABAergic system and the enhancement of glutamatergic transmission in cortical brain areas. This leads to increased vigilance and improved cognitive functions without the pronounced sympathetic activation characteristic of classic stimulants. MODACARE also affects histamine receptors in the hypothalamus, which further contributes to maintaining wakefulness. It is important to note that the drug does not disrupt the architecture of night sleep under the correct dosage regimen, as its action gradually declines toward the evening. Thanks to this, patients can maintain a normal sleep and rest cycle even with long-term use of MODACARE.

Dosage of MODACARE

The standard recommended dose of MODACARE for adult patients is 200 mg once daily, usually in the morning. For narcolepsy and idiopathic hypersomnia, this dose is optimal for most patients and provides a sustained therapeutic effect throughout the day. In some cases, the physician may initiate treatment at a lower dose — 100 mg per day — to assess individual tolerance to the drug and gradually increase it to the therapeutic level. Elderly patients or individuals with impaired hepatic function may require dose adjustment, as modafinil metabolism may be slowed down in such cases. The maximum daily dose of MODACARE should not exceed 400 mg, as further increase does not enhance the therapeutic effect but raises the risk of adverse reactions.

The duration of the treatment course with MODACARE is determined individually depending on the diagnosis and the patient's response to therapy. In chronic conditions such as narcolepsy, the drug can be used long-term; however, the doctor should periodically assess the need to continue treatment and the possibility of dose reduction. For patients with shift work sleep disorder, MODACARE is usually prescribed on an as-needed basis — only on days when a person works a night shift or needs to be active at an unusual time. In such cases, the drug is taken one hour before the start of the work period, which allows reaching the maximum concentration of the active substance right when increased vigilance is required. It is important not to take MODACARE late in the afternoon or evening, as this may disrupt nighttime sleep.

If a regular dose of MODACARE is missed, the patient should take the drug as soon as possible if there are more than six hours left until the next scheduled dose. If the missed dose is noticed closer to the evening, it is better to skip it entirely and return to the normal schedule the next day to avoid insomnia. Doubling the dose to compensate for a missed one is strictly not recommended, as this increases the risk of side effects. Patients with severe renal impairment should use MODACARE with caution and under medical supervision, as the excretion of drug metabolites may be delayed. Any change in dosage or administration regimen must be agreed upon with the prescribing physician.

How to take MODACARE correctly?

MODACARE should be taken orally with a sufficient amount of water, regardless of food intake. However, it should be considered that taking the drug with fatty food can slow down the rate of absorption of the active component and delay the onset of the therapeutic effect. To achieve maximum efficacy, it is recommended to take MODACARE at the same time every morning, which allows maintaining a stable concentration of modafinil in blood plasma. The tablet should be swallowed whole, without chewing or crushing, as breaking the integrity of the dosage form can affect the release rate of the active substance. Patients who have difficulty swallowing should discuss alternative methods of administration with their doctor.

During treatment with MODACARE, it is important to maintain a regular sleep and rest schedule, as the drug does not replace full nighttime sleep, but only helps maintain alertness during periods when it is necessary. Patients are recommended to avoid consuming caffeinated beverages in large quantities throughout the day, as combining caffeine with modafinil can lead to excessive stimulation of the nervous system and anxiety. You should also refrain from taking MODACARE later than ten to twelve hours before planned sleep time to avoid developing insomnia. If a patient forgot to take the drug in the morning but remembered before noon, the dose can be taken immediately; however, in the afternoon, it is better to postpone taking it until the next morning.

With prolonged use of MODACARE, you should not abruptly stop taking the drug, especially if the patient received high doses for a long time. Gradual dose reduction under medical supervision helps avoid possible withdrawal symptoms such as increased sleepiness, mood swings, or feelings of fatigue. Patients using MODACARE to maintain performance during shift work are advised to take breaks from the drug on weekends to give the body an opportunity to restore natural biorhythms. It is important to remember that MODACARE is not a remedy for ordinary fatigue caused by lack of sleep and should not be used as a substitute for a healthy lifestyle. Before starting the medication, be sure to consult a doctor to determine the appropriateness and safety of such treatment in your specific case.

Side effects of MODACARE

The most common side effects of MODACARE, observed in more than five percent of patients, are headache, nervousness, and sleep disturbances. Headache usually occurs at the beginning of treatment and tends to decrease or disappear during the first days of therapy. Nervousness and anxiety may be associated with the stimulating effect of the drug on the central nervous system and are more frequently observed in patients prone to anxiety disorders. Sleep disturbances, particularly insomnia, usually occur when taking MODACARE later than the recommended time or when exceeding the prescribed dose. Patients may also experience dry mouth, decreased appetite, and nausea, which are usually mild or moderate in nature and do not require discontinuation of the drug.

Less common adverse reactions to MODACARE include tachycardia, increased blood pressure, dizziness, and visual disturbances. Patients with cardiovascular diseases should monitor blood pressure and pulse rate particularly closely during treatment, as modafinil can cause a moderate increase in sympathetic activity. In rare cases, the development of allergic reactions is possible, including skin rash, itching, urticaria, and angioedema. Severe skin reactions such as Stevens-Johnson syndrome or toxic epidermal necrolysis pose a particular danger and require immediate medical attention. The appearance of any skin rash while taking MODACARE is grounds for immediate discontinuation of treatment and seeking medical advice.

In the psychiatric sphere, MODACARE can cause increased irritability, emotional lability, and in isolated cases, depressive episodes. Patients with a history of psychiatric disorders require special monitoring during therapy, as the drug may exacerbate existing symptoms. If suicidal thoughts, severe anxiety, or psychotic symptoms appear, seek medical help immediately. The body's individual response to MODACARE may vary depending on age, gender, concomitant diseases, and genetic characteristics of metabolism. Therefore, it is important to inform your doctor about any unusual symptoms that occur during treatment, even if they seem minor.

Contraindications of MODACARE

Absolute contraindications to the use of MODACARE are hypersensitivity to modafinil or any of the auxiliary components of the preparation. Patients with a history of allergic reactions to other psychostimulants should use MODACARE with extreme caution due to the possibility of cross-allergy. The drug is contraindicated in severe cardiovascular diseases, including uncontrolled arterial hypertension, recent myocardial infarction, unstable angina, and severe cardiac arrhythmias. MODACARE should also not be prescribed to patients with psychotic disorders in the active phase, as the stimulating effect on the central nervous system can provoke an exacerbation of psychotic symptoms. In patients with severe hepatic impairment, the drug is contraindicated due to impaired metabolism and the risk of accumulation of the active substance in the body.

Relative contraindications in which MODACARE should be used with caution and under close medical supervision include moderate arterial hypertension, stable angina, and mild cardiac arrhythmias. Regular monitoring of blood pressure and electrocardiogram during treatment is recommended for patients with these conditions. MODACARE is not recommended for use in children and adolescents under eighteen years of age, as safety and efficacy in this age group have not been adequately studied. Elderly patients may require a dose reduction due to an age-related decline in liver and kidney function, which affects the rate of drug clearance. In case of a history of substance abuse, MODACARE should be prescribed with caution, although the addiction potential of the drug is significantly lower than that of traditional stimulants.

The use of MODACARE during pregnancy is not recommended, as animal studies have shown potential adverse effects on fetal development, and controlled studies in pregnant women have not been conducted. Women of childbearing potential taking MODACARE should use reliable methods of contraception during treatment and for two months after its completion. The drug passes into breast milk, so breastfeeding during MODACARE therapy is contraindicated. If administration of the drug is necessary during lactation, breastfeeding should be discontinued. Before starting treatment with MODACARE, be sure to inform your doctor about all existing health conditions, especially heart, liver, kidney, and mental health issues, as well as all medications you take on a regular basis.

Interaction of MODACARE with other drugs and alcohol

MODACARE can interact with many medications, so before starting treatment, it is necessary to inform your doctor about all drugs the patient is taking. Special attention should be paid to hormonal contraceptives, as modafinil induces liver enzymes, leading to accelerated metabolism of estrogens and progestins and reduced contraceptive efficacy. Women taking MODACARE are advised to use additional or alternative methods of contraception. The drug can also reduce the efficacy of cyclosporine, warfarin, and certain antiepileptic agents, requiring adjustment of their dosage and regular monitoring of relevant laboratory parameters. Concomitant use of MODACARE with monoamine oxidase inhibitors is contraindicated due to the risk of developing a hypertensive crisis.

Consumption of alcohol during treatment with MODACARE is not recommended, as combining the stimulating effect of the drug with the depressant effect of alcohol creates an unpredictable load on the central nervous system. Alcohol can mask or worsen the side effects of MODACARE, particularly dizziness, impaired coordination, and decreased reaction speed. In addition, the patient may not feel the usual intoxication, which increases the risk of excessive alcohol consumption and the development of alcohol poisoning. MODACARE may affect the ability to drive vehicles and operate machinery, especially at the start of treatment or when changing the dose. Patients should assess their individual response to the drug before driving or performing potentially dangerous activities that require increased concentration and quick reactions.

Where to buy MODACARE in Ukraine

MODACARE is a prescription drug, so its purchase is possible only with a valid prescription from a doctor. The drug is available in many pharmacy chains in Ukraine, as well as in specialized online pharmacies that deliver medicines subject to prescription confirmation. Before purchasing MODACARE, it is recommended to clarify the availability of the drug at a specific pharmacy, as demand may exceed supply in certain regions. The cost of the drug may vary depending on the pharmacy chain, region, and packaging size, so it is advisable to compare prices across several sources before buying. Store MODACARE in a dry place protected from light at a temperature not exceeding twenty-five degrees Celsius, out of the reach of children. The shelf life of the drug is usually three years from the date of manufacture, after which the use of the drug is strictly prohibited.

When buying MODACARE online, you should apply only to verified pharmacy services that have an appropriate license for retail trade in medicines. Avoid purchasing the drug on dubious internet platforms or from private individuals, as in such cases there is a high risk of receiving a counterfeit or low-quality product. Before starting the use of MODACARE, be sure to consult a doctor regarding the appropriateness of prescribing the drug in your specific case. Remember that self-medication can be dangerous to your health, and the body's individual response to the drug may differ from expected. Only a qualified medical professional can evaluate the benefit-risk ratio of using MODACARE, taking into account all the features of your health condition.

Free delivery from UAH 1000

Across Ukraine

Featured

Order with delivery

Self-medication can be dangerous to your health. Consult a doctor before using this medication..